News

Media

Conferences

Publications

Clinical

Events

Resources

Hepatitis

The Pharmacy Times® Hepatitis Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of distinct diseases that cause inflammation of the liver, including hepatitis A, B, C, and D.

Latest News

Photomicrograph of liver biopsy in a patient with cirrhosis, showing bridging septal fibrosis and regenerative nodules.

FDA Grants Denifanstat Breakthrough Therapy Designation for Treatment of MASH

By Luke Halpern, Assistant Editor

October 2nd 2024

Positive trial results laid the groundwork for the designation.

Human liver anatomy with hepatitis B virus.

Minority of Hematology Patients Receive Hepatitis B Screening Prior to Intravenous Immunoglobulin Exposure

By Luke Halpern, Assistant Editor

July 29th 2024

Image Credit: © eddows - stock.adobe.com

Persistent Epigenetic Changes in Immune Cells Following Hepatitis C Recovery

By Alexandra Gerlach, Associate Editor

July 26th 2024

Pharmacist telling a female patient about her treatment

Pharmacists Boost Hepatitis D Treatment Success with Hands-On Education

By Ava Landry, PharmD Candidate

July 9th 2024

Hepatitis D, Liver | Image Credit: mi_viri - stock.adobe.com

Bulevirtide in Combination With PegInterferon Results In Undetectable Hepatitis D RNA Post-Treatment

By Ashley Gallagher, Associate Editor

July 7th 2024

More News

Insurers Continue to Restrict Access to Hepatitis C Treatments

Jennifer Barrett, Associate Editor

June 8th 2018

Insurers Continue to Deny Coverage for Life-Saving Hepatitis C Drugs at High Rates

Jennifer Barrett, Associate Editor

June 8th 2018

Patients with both private and public insurers face high denial rates across the United States for life-saving hepatitis C drugs, despite changes in restrictions and increased price competition.

Hepatitis C Virus Guideline Updated for Unique Populations

Jennifer Gershman, PharmD, CPh, PACS

May 29th 2018

The hepatitis C virus (HCV) guidelines for unique populations have recently been updated.

Improvement Needed to Reduce Hepatitis B Virus Prevalence Worldwide

Jennifer Barrett, Associate Editor

April 12th 2018

Access to diagnosis and treatment must be improved worldwide to meet target goals for the elimination of viral hepatitis.

New Leading Causes of Death Emerge in United States

Kevin Kunzmann

April 11th 2018

US report indicates new drivers of death have emerged over time and have continued to unequally affect residents at the state level.

Shorter HCV Regimen Effective in Black Patients

Laurie Toich, Associate Editor

March 22nd 2018

Black patients may be eligible for a shorter course of hepatitis C virus treatment.

New Hepatitis C Virus Subtype Resistant to Antivirals

Kenneth Bender, PharmD, MA

March 20th 2018

A recently-discovered hepatitis C virus subtype may complicate treatment.

Trending News Today: Opioid Overdoses Surge Among Native Americans, Alaska Natives

Laurie Toich, Associate Editor

March 15th 2018

Top news of the day from across the health care landscape.

Trending News Today: Michigan Settles HCV Drug Access Lawsuit

Laurie Toich, Associate Editor

March 15th 2018

Top news of the day from across the health care landscape.

Organ-on-Chip Technology Simulates Human Reaction to Hepatitis B Virus

Gina Kokosky, Editorial Intern

February 26th 2018

An artificial liver infected with hepatitis B demonstrates physiological reaction of a real human liver.

Legislator Calls on HHS Secretary to Take Action Against Hepatitis C Drug Costs

Gina Kokosky, Editorial Intern

February 22nd 2018

Health and Human Services Secretary Alex Azar could take action to help millions of Americans gain access to necessary drugs.

Trending News Today: CDC Now Recommending Use of FluMist Vaccine

Laurie Toich, Associate Editor

February 22nd 2018

Top news of the day from across the health care landscape.

Trending News Today: HHS Could Override Hepatitis C Drug Patents

Laurie Toich, Associate Editor

February 22nd 2018

Top news of the day from across the health care landscape.

Hepatitis C: The Bane of Baby Boomers, Though Treatable

Jeannette Y. Wick, RPh, MBA, FASCP

February 22nd 2018

More than 3 million Americans have chronic hepatitis C virus, and physicians diagnose about 17,000 new cases annually.

Drug Attacks Hepatitis B Virus Capsid

Laurie Toich, Associate Editor

February 21st 2018

An experimental antiviral drug shows promise fighting multiple infectious diseases.

Direct-Acting Antivirals Reduce HCV-Related Cellular Changes

Elizabeth Kukielka, PharmD

February 20th 2018

Patients who achieved hepatitis C virus eradication experienced a reduction in hepatic steatosis and fibrosis.

CDC Tracks Adverse Events Related to Hepatitis B Vaccine

Kelsey Fontneau, 2018 PharmD Candidate, the University of Connecticut School of Pharmacy

February 12th 2018

Researchers from the CDC assessed adverse effects (AEs) following HepB vaccinations using the Vaccine Adverse Event Reporting System (VAERS).

Pediatric, Adolescent Vaccination Schedule Updated

Kristen Coppock, MA

February 9th 2018

The CDC and the American Academy of Pediatrics released an updated vaccination schedule.

Inflammatory Changes to T Cells Could Lead to Severe Viral Hepatitis

Laurie Toich, Associate Editor

January 29th 2018

T cell alterations could exacerbate acute hepatitis infections.

Injection Drug Users Benefit from Hepatitis C Treatment

Laurie Toich, Associate Editor

January 18th 2018

Nearly all people who inject drugs with hepatitis C virus achieved a sustained virologic response at 12 weeks.

Ribavirin Remains a Key Factor in Successful Treatment of Hepatitis C

Kenneth Bender

January 11th 2018

Ribavirin steady-state serum levels correspond to high rates of efficacy and low adverse effect from direct-acting antiviral drugs for difficult-to-treat hepatitis C virus.